NCT07731828
- Conditions
- CERVICAL NEOPLASMS, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
- Locations
-
- The Affiliated Hospital of Nanjing Medical University Nanjing, Jiangsu, China
Clinical trial condition
Uterine Diseases
Explore clinical trials studying Uterine Diseases. Study availability and eligibility vary by location and protocol.
3,037 public trials
691 recruiting studies
Uterine Diseases trial results
NCT07022483
- Conditions
- Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +10 more
- Locations
-
- Broward Health Medical Center Fort Lauderdale, Florida, United States
- Miami Cancer Institute Miami, Florida, United States
- Mount Sinai Medical Center Miami Beach, Florida, United States
- Parkview Research Center Fort Wayne, Indiana, United States
NCT06529809
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +11 more
- Locations
-
- Washington University School of Medicine St Louis, Missouri, United States
- Conditions
- Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +11 more
- Locations
-
- University of South Alabama, Mitchell Cancer Institute ( Site 6033) Mobile, Alabama, United States
- Alaska Women's Cancer Care ( Site 6036) Anchorage, Alaska, United States
- CHAO Family Comprehensive Cancer Center and Ambulatory Care ( Site 5014) Irvine, California, United States
- University of California, Irvine (UCI) Health - UC Irvine Medical Center ( Site 6020) Orange, California, United States
NCT05503797
- Conditions
- Adenocarcinoma, Adnexal Diseases, Biliary Tract Diseases, +52 more
- Locations
-
- Precision NextGen Oncology & Research Center Beverly Hills, California, United States
- UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
- University of California Los Angeles Rheumatology Westwood, Los Angeles, California, United States
- Norwalk Hospital Norwalk, Connecticut, United States
Recruiting
A Study of Sacituzumab Govitecan (IMMU-132) in Patients With Recurrent or Persistent Cervical Cancer
NCT05838521
- Conditions
- Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
- Locations
-
- Smilow Cancer Hospital at Yale New Haven New Haven, Connecticut, United States
- Cleveland Clinic Cleveland, Ohio, United States
NCT05112601
- Conditions
- Adenocarcinoma, Adnexal Diseases, Carcinoma, +28 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- University Cancer and Blood Center LLC Athens, Georgia, United States
- Augusta University Medical Center Augusta, Georgia, United States
- Saint Alphonsus Cancer Care Center-Boise Boise, Idaho, United States
NCT07216703
- Conditions
- Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +12 more
- Locations
-
- Florida Cancer Specialists - South ( Site 7001) Fort Myers, Florida, United States
- Mount Sinai Comprehensive Cancer Center ( Site 5043) Miami Beach, Florida, United States
- Mount Sinai Comprehensive Cancer Center ( Site 6000) Miami Beach, Florida, United States
- Florida Cancer Specialists - East ( Site 7000) West Palm Beach, Florida, United States
NCT07453459
- Conditions
- Cervical Cancer, Communicable Diseases, DNA Virus Infections, +23 more
- Locations
-
- Washington University School of Medicine St Louis, Missouri, United States
NCT06465069
- Conditions
- Adnexal Diseases, Advanced Solid Tumor, Bladder Cancer, +72 more
- Locations
-
- City of Hope National Medical Center Duarte, California, United States
- University of California, San Diego (UCSD) - Moores Cancer Center La Jolla, California, United States
- UCLA Department of Medicine-Hematology/Oncology Los Angeles, California, United States
- Sarah Cannon Research Institute at HealthOne Denver, Colorado, United States